Zhiyuan Hu Selected Research

Peptoids

1/2022	Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
1/2021	Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
2/2020	Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.
1/2019	Detection of Parkinson's Disease through the Peptoid Recognizing α-Synuclein in Serum.
8/2017	Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.
1/2015	Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyuan Hu Research Topics

Disease

66	Neoplasms (Cancer) 01/2022 - 08/2004
24	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2004
9	Circulating Neoplastic Cells 01/2022 - 04/2013
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2015
6	Lung Neoplasms (Lung Cancer) 01/2020 - 03/2009
5	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2019
3	Disease Progression 01/2019 - 01/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 04/2007
2	Pathologic Complete Response 01/2022 - 03/2009
2	Triple Negative Breast Neoplasms 01/2022 - 12/2019
2	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2008
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 04/2007
2	Hypertension (High Blood Pressure) 01/2019 - 01/2018
2	Carcinogenesis 01/2018 - 01/2017
2	Weight Loss (Weight Reduction) 09/2007 - 04/2004
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Cognitive Dysfunction 02/2020
1	Infections 01/2020
1	Pneumonia (Pneumonitis) 01/2019

Drug/Important Bio-Agent (IBA)

28	Peptides (Polypeptides)IBA 01/2022 - 04/2007
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2009
12	Pharmaceutical PreparationsIBA 07/2020 - 04/2007
11	Phenobarbital (Luminal)FDA Link 11/2018 - 08/2004
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
10	Estrogen ReceptorsIBA 01/2022 - 08/2004
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2008
7	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
7	Liposomes (Liposome)IBA 01/2020 - 04/2016
6	PeptoidsIBA 01/2022 - 01/2015
6	Biological ProductsIBA 01/2019 - 01/2006
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
4	Trastuzumab (Herceptin)FDA Link 10/2020 - 01/2017
4	Albumin-Bound Paclitaxel FDA Link 12/2019 - 01/2015
4	AntibodiesIBA 01/2019 - 08/2004
4	human ERBB2 proteinIBA 01/2018 - 04/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 04/2004
3	Monoclonal AntibodiesIBA 12/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
3	LigandsIBA 01/2019 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2007
3	Nucleic AcidsIBA 01/2018 - 01/2012
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 04/2006
3	Peptide LibraryIBA 01/2016 - 04/2007
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2018
2	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 12/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2018
2	plastinIBA 12/2019 - 01/2019
2	MicellesIBA 01/2019 - 06/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2018
2	EnzymesIBA 08/2018 - 04/2007
2	ImmunosorbentsIBA 08/2018 - 04/2007
2	Hormones (Hormone)IBA 01/2018 - 04/2006
2	AmberIBA 01/2018 - 03/2016
2	Keratins (Keratin)IBA 01/2018 - 08/2004
2	AlbuminsIBA 01/2017 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2014 - 12/2008
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 09/2007 - 04/2004
1	Circular RNAIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	ProdrugsIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	B7-H1 AntigenIBA 12/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Drug CarriersIBA 07/2020
1	Amyloid beta-PeptidesIBA 02/2020
1	Long Noncoding RNAIBA 01/2020
1	AntigensIBA 01/2020
1	GlycosidesIBA 01/2020
1	EpitopesIBA 01/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	salinomycinIBA 01/2020
1	hyperosideIBA 01/2020
1	3-hydroxyflavoneIBA 01/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2019
1	PolymersIBA 01/2019
1	ElementsIBA 01/2019
1	IntegrinsIBA 01/2019
1	isothiocyanic acidIBA 01/2019
1	apatinibIBA 01/2019
1	camrelizumabIBA 01/2019
1	SynucleinsIBA 01/2019
1	Neuropilin-1IBA 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2019
1	diadenosine pyrophosphate (AppA)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	aconitic anhydrideIBA 01/2019
1	Cell-Penetrating PeptidesIBA 01/2019

Therapy/Procedure

32	Therapeutics 01/2022 - 04/2007
4	Precision Medicine 01/2019 - 01/2019
3	Immunotherapy 01/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2021 - 03/2009
2	Neoadjuvant Therapy 01/2022 - 11/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Nanospheres 01/2019